KALA
KALA BIO, Inc.
Company overview
- Market capitalization
- $8.37M
- Employees
- 6
- Latest publication
- 2026-09-29
About KALA BIO, Inc.
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 254,000USD | — | 0USD |
| Cost Of Revenue | 54,000USD | — | 128,000USD | 67,000USD | 68,000USD | 69,000USD | — | 61,000USD |
| Gross Profit | -54,000USD | — | -128,000USD | -67,000USD | -68,000USD | -69,000USD | — | -61,000USD |
| Research Development | 61,000USD | 366,000USD | 6,127,000USD | 6,232,000USD | 6,055,000USD | 5,189,000USD | 5,168,000USD | 5,256,000USD |
| Selling General Administrative | 1,741,000USD | 9,859,000USD | 4,534,000USD | 4,643,000USD | 4,593,000USD | 4,201,000USD | — | 4,317,000USD |
| Total Operating Expenses | 1,802,000USD | 10,225,000USD | 7,239,000USD | 11,028,000USD | 10,669,000USD | 9,390,000USD | — | 9,573,000USD |
| Operating Income | -1,802,000USD | -10,225,000USD | -7,239,000USD | -11,028,000USD | -10,669,000USD | -9,459,000USD | — | -9,634,000USD |
| Interest Income | 74,000USD | 0USD | 270,000USD | 407,000USD | 463,000USD | 478,000USD | — | 504,000USD |
| Interest Expense | 141,000USD | 141,000USD | 963,000USD | 1,081,000USD | 1,091,000USD | 1,392,000USD | — | 1,458,000USD |
| Net Interest Income | 74,000USD | -141,000USD | -693,000USD | -674,000USD | -628,000USD | -914,000USD | — | -954,000USD |
| Income Before Tax | -1,621,000USD | 686,000USD | -7,564,000USD | -11,155,000USD | -8,947,000USD | -8,175,000USD | — | -9,579,000USD |
| Net Income | -1,621,000USD | 686,000USD | -7,564,000USD | -11,155,000USD | -8,947,000USD | -8,175,000USD | -8,950,000USD | -9,579,000USD |
| Net Income From Continuing Ops | -1,621,000USD | 686,000USD | -7,564,000USD | -11,155,000USD | -8,947,000USD | -8,175,000USD | — | -9,579,000USD |
| Ebit | -10,225,000USD | — | -6,601,000USD | -10,074,000USD | -7,856,000USD | -9,459,000USD | — | -9,634,000USD |
| Ebitda | -1,802,000USD | — | -6,473,000USD | -10,007,000USD | -7,788,000USD | -9,390,000USD | — | -9,573,000USD |
| Depreciation And Amortization | 54,000USD | — | 128,000USD | 67,000USD | 68,000USD | 69,000USD | — | 61,000USD |
| Reconciled Depreciation | 0USD | 54,000USD | 128,000USD | 67,000USD | 68,000USD | 69,000USD | — | 61,000USD |
| Total Other Income Expense Net | 181,000USD | 11,052,000USD | -325,000USD | -127,000USD | 1,722,000USD | 1,284,000USD | — | 55,000USD |
| Unclassified Operating Expenses | — | — | -3,422,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | -22,724USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | DisclosurePreliminary | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 3,892,000USD | 11,240,000USD | 6,362,000USD | 6,074,000USD | 0USD |
| Research Development | 18,780,000USD | 22,094,000USD | 18,586,000USD | 17,653,000USD | 11,515,000USD | 18,352,000USD | 27,275,000USD | 29,290,000USD |
| Selling General Administrative | 23,629,000USD | 18,340,000USD | 20,567,000USD | 65,035,000USD | 105,061,000USD | 81,068,000USD | 65,015,000USD | 35,431,000USD |
| General And Administrative Expenses | 23,629,000USD | 18,340,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 39,161,000USD | 40,983,000USD | 39,663,000USD | 85,598,000USD | 141,485,000USD | 102,593,000USD | 94,298,000USD | 63,766,000USD |
| Operating Income | -39,161,000USD | -40,983,000USD | -39,663,000USD | -81,706,000USD | -130,245,000USD | -96,231,000USD | -88,224,000USD | -64,721,000USD |
| Total Other Income Expense Net | 12,181,000USD | 2,472,000USD | -2,536,000USD | 36,884,000USD | -12,360,000USD | -8,096,000USD | -6,123,000USD | -2,017,000USD |
| Interest Income | 1,140,000USD | 2,056,000USD | 2,711,000USD | 664,000USD | 104,000USD | 493,000USD | 2,357,000USD | 1,687,000USD |
| Interest Expense | 3,276,000USD | 5,783,000USD | 5,814,000USD | 7,266,000USD | 8,380,000USD | 8,589,000USD | 8,480,000USD | 3,314,000USD |
| Income Before Tax | -26,980,000USD | -38,511,000USD | -42,199,000USD | -44,822,000USD | -142,605,000USD | -104,327,000USD | -94,347,000USD | -66,738,000USD |
| Income Tax Expense | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 1,297,000USD |
| Net Income | -26,980,000USD | -38,511,000USD | -42,199,000USD | -44,822,000USD | -142,605,000USD | -104,327,000USD | -94,347,000USD | -66,738,000USD |
| Net Income Applicable To Common Shares | -26,980,000USD | -38,511,000USD | -42,199,000USD | -44,822,000USD | -142,605,000USD | -104,327,000USD | -94,347,000USD | -66,738,000USD |
| Cost Of Revenue | — | — | — | — | — | — | — | 955,000USD |
| Gross Profit | — | — | — | — | — | — | — | -955,000USD |
| Net Interest Income | — | — | — | — | — | — | — | -1,627,000USD |
| Net Income From Continuing Ops | — | — | — | — | — | — | — | -66,738,000USD |
| Ebit | — | — | — | — | — | — | — | -64,721,000USD |
| Ebitda | — | — | — | — | — | — | — | -63,766,000USD |
| Depreciation And Amortization | — | — | — | — | — | — | — | 955,000USD |
| Reconciled Depreciation | — | — | — | — | — | — | — | 955,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 10,582,000USD | 12,318,000USD | 9,490,000USD | 25,021,000USD | 36,053,000USD | 48,252,000USD | 55,483,000USD | 54,079,000USD |
| Cash And Equivalents | 229,000USD | 1,764,000USD | 7,557,000USD | 21,096,000USD | 31,942,000USD | 42,222,000USD | 51,181,000USD | 49,202,000USD |
| Cash And Short Term Investments | 7,229,000USD | 8,764,000USD | — | — | — | — | — | — |
| Short Term Investments | 7,000,000USD | 7,000,000USD | — | — | — | — | — | — |
| Total Current Assets | 10,582,000USD | 12,318,000USD | 9,490,000USD | 24,274,000USD | 33,663,000USD | 45,717,000USD | 52,797,000USD | 51,279,000USD |
| Other Current Assets | 3,353,000USD | 3,554,000USD | 1,933,000USD | 3,178,000USD | 1,721,000USD | 3,495,000USD | 1,616,000USD | 2,077,000USD |
| Total Liabilities | 1,538,000USD | 1,557,000USD | 2,494,000USD | 33,686,000USD | 39,259,000USD | 42,544,000USD | 43,151,000USD | 47,220,000USD |
| Total Current Liabilities | 1,538,000USD | 1,557,000USD | 2,494,000USD | 32,574,000USD | 16,016,000USD | 22,975,000USD | 16,956,000USD | 23,867,000USD |
| Total Stockholder Equity | 9,044,000USD | 10,761,000USD | 6,996,000USD | -8,665,000USD | -3,206,000USD | 5,708,000USD | 12,332,000USD | 6,859,000USD |
| Total Equity Including Noncontrolling Interest | 9,044,000USD | 10,761,000USD | 6,996,000USD | -8,665,000USD | -3,206,000USD | 5,708,000USD | 12,332,000USD | 6,859,000USD |
| Accounts Payable | 1,142,000USD | 1,044,000USD | 986,000USD | 917,000USD | 658,000USD | 931,000USD | 628,000USD | 711,000USD |
| Common Stock | 20,000USD | 19,000USD | 28,000USD | 7,000USD | 7,000USD | 6,000USD | 6,000USD | 5,000USD |
| Retained Earnings | -698,102,000USD | -696,521,000USD | -694,900,000USD | -695,586,000USD | -688,022,000USD | -676,867,000USD | -667,920,000USD | -659,745,000USD |
| Short Long Term Debt | — | — | — | 56,822,000USD | 19,022,000USD | 31,006,000USD | 10,336,000USD | 35,954,000USD |
| Property Plant Equipment Net | — | — | — | 603,000USD | 2,164,000USD | 2,296,000USD | 2,440,000USD | 2,540,000USD |
| Short Term Debt | — | — | — | 420,000USD | 406,000USD | 393,000USD | 380,000USD | 368,000USD |
| Long Term Debt | — | — | — | — | 18,786,000USD | 15,121,000USD | 20,102,000USD | 17,162,000USD |
| Other Current Liabilities | — | — | — | — | — | — | — | 4,497,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,490,000USD | 55,483,000USD | 55,949,000USD | 86,820,000USD | 139,427,000USD | 221,606,000USD | 154,323,000USD | 220,966,000USD |
| Cash And Equivalents | 7,557,000USD | 51,181,000USD | 50,895,000USD | 70,495,000USD | 92,136,000USD | 77,264,000USD | — | — |
| Total Current Assets | 9,490,000USD | 52,797,000USD | 52,870,000USD | 85,942,000USD | 124,366,000USD | 171,379,000USD | 105,484,000USD | 177,028,000USD |
| Other Current Assets | 1,933,000USD | 1,616,000USD | 1,975,000USD | 7,657,000USD | 6,204,000USD | 3,006,000USD | 3,824,000USD | 477,000USD |
| Total Liabilities | 2,494,000USD | 43,151,000USD | 48,445,000USD | 67,846,000USD | 122,623,000USD | 121,611,000USD | 124,631,000USD | 115,988,000USD |
| Total Current Liabilities | 2,494,000USD | 16,956,000USD | 8,346,000USD | 25,685,000USD | 37,422,000USD | 22,225,000USD | 24,774,000USD | 17,010,000USD |
| Total Stockholder Equity | 6,996,000USD | 12,332,000USD | 7,504,000USD | 18,974,000USD | 16,804,000USD | 99,995,000USD | 29,692,000USD | 104,978,000USD |
| Total Equity Including Noncontrolling Interest | 6,996,000USD | 12,332,000USD | 7,504,000USD | 18,974,000USD | 16,804,000USD | 99,995,000USD | 29,692,000USD | 104,978,000USD |
| Accounts Payable | 986,000USD | 628,000USD | 919,000USD | 2,832,000USD | 4,899,000USD | 1,724,000USD | 2,518,000USD | 5,446,000USD |
| Common Stock | 28,000USD | 6,000USD | 3,000USD | 2,000USD | 66,000USD | 59,000USD | 36,000USD | 34,000USD |
| Retained Earnings | -694,900,000USD | -667,920,000USD | -629,409,000USD | -587,210,000USD | -542,388,000USD | -399,783,000USD | -295,456,000USD | -201,109,000USD |
| Short Long Term Debt | — | 10,336,000USD | — | 10,000,000USD | — | — | — | — |
| Long Term Debt | — | 20,102,000USD | 34,190,000USD | 37,937,000USD | 78,929,000USD | 72,243,000USD | 71,184,000USD | 70,226,000USD |
| Property Plant Equipment Net | — | 2,440,000USD | 2,778,000USD | 416,000USD | 4,021,000USD | 31,019,000USD | 32,479,000USD | 31,732,000USD |
| Short Term Debt | — | 380,000USD | 334,000USD | 13,000USD | 711,000USD | 1,530,000USD | 1,327,000USD | 463,000USD |
| Other Current Liabilities | — | — | 6,018,000USD | 8,910,000USD | 20,986,000USD | 18,971,000USD | 20,929,000USD | 11,101,000USD |
| Deferred Revenue | — | — | — | 4,189,000USD | — | — | — | — |
| Net Receivables | — | — | — | 195,000USD | 15,345,000USD | 9,604,000USD | 11,563,000USD | — |
| Inventory | — | — | — | — | 8,639,000USD | 5,229,000USD | 4,648,000USD | 4,095,000USD |
| Cash And Short Term Investments | — | — | — | — | — | 153,540,000USD | — | — |
| Short Term Investments | — | — | — | — | — | 76,276,000USD | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | 4,000USD | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q3 20222022-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Stock Based Compensation | -607,000USD | 6,594,000USD | 4,550,000USD | 6,295,000USD | 4,259,000USD | 5,089,000USD | 2,686,000USD | 6,048,000USD |
| Change To Liabilities | -956,000USD | -2,291,000USD | -1,566,000USD | -2,472,000USD | -1,276,000USD | -2,355,000USD | -6,714,000USD | 6,964,000USD |
| Change In Working Capital | -1,264,000USD | -1,273,000USD | -82,000USD | -310,000USD | -2,923,000USD | 11,335,000USD | 6,836,000USD | -363,000USD |
| Operating Cash Flow | -4,430,000USD | -27,435,000USD | -16,558,000USD | -24,784,000USD | -20,059,000USD | -20,231,000USD | -17,279,000USD | -65,173,000USD |
| Investing Cash Flow | -7,000,000USD | -15,000USD | -16,000USD | -139,000USD | -49,000USD | -422,000USD | -10,141,000USD | 62,666,000USD |
| Financing Cash Flow | 4,102,000USD | -2,635,000USD | -2,665,000USD | 23,230,000USD | 23,410,000USD | 5,971,000USD | 5,931,000USD | -39,728,000USD |
| Change In Cash | -7,328,000USD | -30,085,000USD | -19,239,000USD | -1,693,000USD | 3,302,000USD | -14,682,000USD | -21,489,000USD | -42,235,000USD |
| End Cash Flow | 229,000USD | 21,096,000USD | 31,942,000USD | 49,202,000USD | 54,197,000USD | 56,063,000USD | 49,256,000USD | 52,643,000USD |
| Depreciation | — | 263,000USD | 135,000USD | 190,000USD | 127,000USD | 233,000USD | 154,000USD | 457,000USD |
| Net Debt Issuance | — | -88,000USD | -58,000USD | -18,000USD | — | — | — | -29,000USD |
| Common Stock Issuance | — | 73,000USD | 13,000USD | 77,000USD | 21,000USD | 46,000USD | 6,000USD | 301,000USD |
| Unclassified Financing Cash Flow | — | -2,620,000USD | -2,620,000USD | 23,171,000USD | 23,389,000USD | 5,925,000USD | 5,925,000USD | -40,000,000USD |
| Other Non Cash Items | — | — | — | -129,000USD | -117,000USD | 4,322,000USD | 47,000USD | -2,659,000USD |
| Change To Account Receivables | — | — | — | — | — | 78,000USD | 78,000USD | 15,143,000USD |
| Change To Inventory | — | — | — | — | — | 7,544,000USD | 2,300,000USD | -1,011,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Stock Based Compensation | -471,000USD | 401,000USD | 2,044,000USD | — | 2,310,000USD | 2,094,000USD | 2,036,000USD | 1,883,000USD |
| Change To Liabilities | -937,000USD | — | — | — | -578,000USD | — | — | — |
| Change In Working Capital | -1,563,000USD | -1,388,000USD | -2,275,000USD | — | -1,583,000USD | 1,028,000USD | 1,287,000USD | -2,048,000USD |
| Operating Cash Flow | -2,895,000USD | — | — | -16,558,000USD | -8,824,000USD | — | — | — |
| Investing Cash Flow | -7,000,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 4,102,000USD | — | — | — | -135,000USD | — | — | — |
| Change In Cash | -5,793,000USD | -13,539,000USD | -10,846,000USD | — | -8,959,000USD | 1,979,000USD | -4,995,000USD | 5,719,000USD |
| End Cash Flow | 1,764,000USD | — | — | 31,942,000USD | 42,222,000USD | — | — | — |
| Net Income | — | 686,000USD | -7,564,000USD | — | — | -8,175,000USD | -8,950,000USD | -9,579,000USD |
| Depreciation | — | 54,000USD | 128,000USD | — | 68,000USD | 69,000USD | 63,000USD | 61,000USD |
| Other Non Cash Items | — | 935,000USD | -3,210,000USD | — | — | 386,000USD | 839,000USD | 468,000USD |
| Total Cash From Operating Activities | — | -4,556,000USD | -10,877,000USD | — | — | -4,598,000USD | -4,725,000USD | -9,215,000USD |
| Capital Expenditures | — | 0USD | -16,000USD | — | — | -69,000USD | -49,000USD | -36,000USD |
| Free Cash Flow | — | -4,556,000USD | -10,861,000USD | — | — | -4,667,000USD | -4,676,000USD | -9,251,000USD |
| Net Borrowings | — | -19,917,000USD | -30,000USD | — | — | -5,027,000USD | -18,000USD | — |
| Total Cash From Financing Activities | — | -8,983,000USD | 30,000USD | — | — | 6,646,000USD | -180,000USD | 14,970,000USD |
| Issuance Of Capital Stock | — | 10,934,000USD | 0USD | — | — | 11,673,000USD | -218,000USD | 14,970,000USD |
| Begin Period Cash Flow | — | 21,096,000USD | 31,942,000USD | — | — | 49,202,000USD | 54,197,000USD | 48,478,000USD |
| End Period Cash Flow | — | 7,557,000USD | 21,096,000USD | — | — | 51,181,000USD | 49,202,000USD | 54,197,000USD |
| Unclassified Operating Cash Flow | — | -5,244,000USD | — | — | — | — | — | — |
| Investments | — | — | 1,000USD | — | — | -69,000USD | -90,000USD | -36,000USD |
| Total Cashflows From Investing Activities | — | — | 1,000USD | — | — | -69,000USD | -90,000USD | -36,000USD |
| Sale Purchase Of Stock | — | — | -13,000USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | -15,000USD | — | — | — | -139,000USD | — |
| Other Cashflows From Financing Activities | — | — | 30,000USD | — | — | — | 56,000USD | -36,000USD |
| Net Debt Issuance | — | — | — | — | -28,000USD | — | — | — |
| Common Stock Issuance | — | — | — | — | 13,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | -120,000USD | — | — | — |
| Change To Inventory | — | — | — | — | — | 0USD | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 317,000USD | 259,000USD | 303,000USD | 537,000USD | 975,000USD | 912,000USD | 843,000USD | 352,000USD |
| Stock Based Compensation | 6,995,000USD | 8,389,000USD | 7,463,000USD | 7,008,000USD | 16,088,000USD | 13,312,000USD | 9,991,000USD | 8,615,000USD |
| Other Non Cash Items | 5,793,000USD | -129,000USD | 4,323,000USD | -2,659,000USD | -5,546,000USD | — | — | -390,000USD |
| Change To Liabilities | -3,535,000USD | -1,819,000USD | -4,326,000USD | -14,002,000USD | 4,945,000USD | -2,687,000USD | 6,860,000USD | 8,056,000USD |
| Change In Working Capital | 185,000USD | 68,000USD | 11,330,000USD | 12,761,000USD | -11,641,000USD | -515,000USD | -20,393,000USD | -1,167,000USD |
| Operating Cash Flow | -31,991,000USD | -29,382,000USD | -27,927,000USD | -78,908,000USD | -108,235,000USD | -90,694,000USD | -92,720,000USD | -54,121,000USD |
| Investing Cash Flow | -15,000USD | -208,000USD | -429,000USD | 62,717,000USD | 70,803,000USD | -78,209,000USD | -1,335,000USD | -1,578,000USD |
| Net Debt Issuance | -92,000USD | -45,000USD | — | -39,000USD | 77,747,000USD | -32,000USD | -30,000USD | 71,927,000USD |
| Common Stock Issuance | 73,000USD | 77,000USD | 46,000USD | 301,000USD | 1,585,000USD | — | — | — |
| Unclassified Financing Cash Flow | -11,599,000USD | 29,844,000USD | 8,460,000USD | -8,204,000USD | -36,778,000USD | 160,660,000USD | 9,012,000USD | 52,177,000USD |
| Financing Cash Flow | -11,618,000USD | 29,876,000USD | 8,506,000USD | -7,942,000USD | 42,554,000USD | 160,628,000USD | 8,982,000USD | 124,104,000USD |
| Change In Cash | -43,624,000USD | 286,000USD | -19,850,000USD | -24,133,000USD | 5,122,000USD | -8,275,000USD | -85,073,000USD | 68,405,000USD |
| End Cash Flow | 7,557,000USD | 51,181,000USD | 50,895,000USD | 70,745,000USD | 94,878,000USD | 89,756,000USD | 98,031,000USD | 183,104,000USD |
| Change To Account Receivables | — | — | 78,000USD | 15,138,000USD | -5,756,000USD | 1,959,000USD | -11,563,000USD | — |
| Change To Inventory | — | — | 7,544,000USD | 1,708,000USD | -6,257,000USD | -2,368,000USD | -4,271,000USD | -3,868,000USD |
| Other Investing Activities | — | — | — | — | -4,653,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | 75,456,000USD | — | — | — |
| Capital Expenditures | — | — | — | — | — | — | -1,335,000USD | -1,578,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.